Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Global VONVENDI Drug Market Outlook

The VONVENDI drug market size is likely to grow in the forecast period of 2025-2034, driven by the rising prevalence of Von Willebrand disease (VWD). VONVENDI drug is widely used in the treatment of Von Willebrand disease (VWD), a blood disorder, which is likely to affect about 1% of the population in the coming years.

VONVENDI Drug Market: Insights

Adults with Von Willebrand disease (VWD), an inherited blood disorder that makes it challenging to form blood clots, can use VONVENDI® to manage bleeds. The only and first treatment for VWD that is recombinant, or created without using human blood, is VONVENDI. There is almost no chance that recombinant goods will come into contact with a disease that can be contracted through contact with contaminated human blood.

A blood glycoprotein, called von Willebrand factor, especially affects platelet adherence during haemostasias. It has a role in a variety of illnesses, including von Willebrand disease, thrombotic thrombocytopenic purpura, Heyde's syndrome, and perhaps hemolytic-uremic syndrome.

Since the symptoms are subtle or nonexistent, many people with von Willebrand disease are unaware of it. Abnormal bleeding is the condition's most typical symptom. The symptoms come in three primary forms. Depending on the nature and severity of the disease, different people experience different amounts of bleeding.

vonvendi drug market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

There are different types of this disease:

  • Type 1: It is the most prevalent and mildest type. Von Willebrand factor levels are lower in the blood of those with type 1 VWD. Bleeding is typically just a concern after surgery, when you get hurt, or when you get a tooth out.
  • Type 2: The Von Willebrand factor malfunctions in those with this kind of VWD. Compared to type 1, bleeding tends to be greater and more frequent.
  • Type 3: The most severe and uncommon kind is type 3. Von Willebrand factor is either very low or absent in people. It is typical to have bleeding from the mouth, nose, and stomach, and injuries can also cause joint and muscle bleeding.

VONVENDI Drug Market Segmentations:

The market can be categorized into the following sections:

Market Breakup by Indication

  • On-demand treatment and control of bleeding episodes
  • Perioperative management of bleeding
    • Elective Surgical Procedure
    • Emergency Surgery
  • Routine prophylaxis
  • Type 3 von Willebrand disease (VWD)
  • Others

Market Breakup by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Market Breakup by End User

  • Hospitals and Clinics
  • Research and Academic Laboratories
  • Others

vonvendi drug market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Region

  • North America
    • United States of America
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others

VONVENDI Drug Market: Epidemiology

Men and women both experience Von Willebrand disease (VWD), which can afflict up to 1% of the general population. However, due to the increased bleeding that VWD causes during menstruation, pregnancy, and postpartum, women are more prone to suffer its symptoms. More than 14,600 men, women, and kids received treatment for VWD between 2012 and 2016 at Haemophilia treatment facilities. Women and girls made up about two-third of the total count.

Von Willebrand disease (VWD) is estimated to affect between 0.6 and 1.3% of the general population (in all its variants), however, only around 1/10 000 people have symptomatic VWD that needs special care. One in one million is the rarity of Type 3 VWD.

The market for Von Willebrand disease treatments is dominated by North America because of its sophisticated healthcare system. A significant rate of increase is anticipated in Asia Pacific in the coming years as the region is expanding their health care infrastructure.

Emergent Treatments and Initiatives in the VONVENDI Drug Market

Different patient aid programmes are being introduced by several businesses, associations, and organisations for those who have been impacted by von Willebrand disease or associated bleeding diseases. By raising public knowledge of the condition, aiding in diagnosis and treatment, these patient assistance initiatives have had a positive effect on the management of von Willebrand disease. This, in turn, has increased the demand for von Willebrand disease treatments worldwide.

For instance, 2020, Domedica and Octapharma AG collaborated to create the WiCare programme, which offers at-home assistance to individuals with von Willebrand disease (vWD).

Therapeutic Landscape of von Willebrand Disease

Von Willebrand factor deficit or dysfunction results in Von Willebrand disease, an inherited bleeding illness. A plasma protein called VWF is what causes platelets to initially adhere to vascular damage sites. Additionally, this protein stabilizes clotting factor VIII (FVIII) in the blood by binding to it.

Menorrhagia, nose, gum bleeding, and protracted bleeding from skin wounds are among the major symptoms of von Willebrand disease. Due to an increase in patient assistance programmes, a promising medication pipeline, and recent drug approvals, the market for von Willebrand disease treatments has grown dramatically over the past ten years.

Desmopressin, clot-stabilizing drugs, replacement therapy, contraceptives, and other medicines are widely used in the treatment of von Willebrand disease. Desmopressin is one of the most common treatments used for von Willebrand disease.

Desmopressin, a primary medication, is frequently supplied via injection, and replacement therapies are also given in this way. During an emergency, injections react very rapidly and are a very efficient medicine delivery method. As a result, during the projected period, the market is also anticipated to grow at a fast pace.

Supplier Landscape of the VONVENDI Drug Market

The VONVENDI drug market report gives an in-depth analysis of the key suppliers involved in the market, sponsors manufacturing the drugs. The key suppliers included in the market are as follows:

  • Baxalta US Inc.
  • Takeda Pharmaceutical Company Limited

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Indication
  • Distribution Channel
  • End User
  • Region
Breakup by Indication
  • On-demand treatment and control of bleeding episodes
  • Perioperative management of bleeding
  • Routine prophylaxis
  • Type 3 Von Willebrand Disease (VWD)
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Breakup by End User
  • Hospitals and Clinics
  • Research and Academic Laboratories
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis 
  • Porter's Five Forces Analysis 
  • Key Indicators for Demand
  • Key Indicators for Price
  • Industry Events, Initiatives, and Trends
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Baxalta US Inc.
  • Takeda Pharmaceutical Company Limited

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market is projected to grow with the rising cases of von Willebrand disease across the globe.

The growth of the market is driven by the rising prevalence of von Willebrand disease and the rising healthcare sector.

The regional markets include North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

The indications include on-demand treatment and control of bleeding episodes, perioperative management of bleeding, routine prophylaxis, and type 3 Von Willebrand disease (VWD), among others.

The distribution channels in the market include hospital pharmacy, retail pharmacy, and online pharmacy.

The major end-users in the market include hospitals and clinics, research and academic laboratories, among others.

The key suppliers of this drug include Baxalta US Inc. and Takeda Pharmaceutical Company Limited.

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124